ID: ALA3604558

Max Phase: Preclinical

Molecular Formula: C22H32BN10O17P3

Molecular Weight: 812.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  BP(=O)(OC[C@H]1O[C@@H](n2c[n+](C)c3c([O-])nc(N)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2c[n+](C)c3c([O-])nc(N)nc32)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C22H32BN10O17P3/c1-30-5-32(15-9(30)17(38)28-21(24)26-15)19-13(36)11(34)7(47-19)3-45-51(23,40)49-53(43,44)50-52(41,42)46-4-8-12(35)14(37)20(48-8)33-6-31(2)10-16(33)27-22(25)29-18(10)39/h5-8,11-14,19-20,34-37H,3-4,23H2,1-2H3,(H6-2,24,25,26,27,28,29,38,39,41,42,43,44)/t7-,8-,11-,12-,13-,14-,19-,20-,51?/m1/s1

Standard InChI Key:  YOCFGPRTDKWCGK-QWWGDFIJSA-N

Associated Targets(non-human)

Eukaryotic translation initiation factor 4E 100 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 812.29Molecular Weight (Monoisotopic): 812.1253AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Ziemniak M, Kowalska J, Lukaszewicz M, Zuberek J, Wnek K, Darzynkiewicz E, Jemielity J..  (2015)  Phosphate-modified analogues of m(7)GTP and m(7)Gppppm(7)G-Synthesis and biochemical properties.,  23  (17): [PMID:26264844] [10.1016/j.bmc.2015.07.052]

Source